TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS EGX:RMDA:
EGYPT'S RAMEDA FY CONSOL NET PROFIT EGP 313.2 MILLION
RAMEDA FY CONSOL REVENUE EGP 4.10 BILLION
Rameda FY Consol Profit EGP 313.2 Million
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda on 6ix
Earlier from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
- Egypt's Rameda Q3 Income EGP 96 Mln
- Egypt's Rameda Borad Proposes To Increase Issued Capital
- SNG: Egypt: Rameda reports 44.3% YoY consolidated profit decline in Q1 2025
Later from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- Egypt's Rameda Q1 Standalone Profit EGP 105.2 Million
- Egypt's RAMEDA Appoints Sherif Ahmed Mohamed El Akhdar As Chairman
- LVP Pharma Raises Stake In Egypt's Rameda To 31.498%
- Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) - EGM Minutes
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda into a list and get an email when it puts out news.
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda